Stocks and Investing
Stocks and Investing
Thu, July 18, 2024
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
[ Thu, Jul 18th 2024
] - WOPRAI
Jason Gerberry Maintained (AXSM) at Hold with Decreased Target to $95 on, Jul 18th, 2024
Jason Gerberry of B of A Securities, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Decreased Target from $97 to $95 on, Jul 18th, 2024.
Jason has made no other calls on AXSM in the last 4 months.
There are 8 other peers that have a rating on AXSM. Out of the 8 peers that are also analyzing AXSM, 0 agree with Jason's Rating of Hold.
These are the ratings of the 8 analyists that currently disagree with Jason
- Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $106 on, Wednesday, June 12th, 2024
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $190 on, Thursday, June 6th, 2024
- Leonid Timashev of "RBC Capital" Maintained at Buy with Increased Target to $130 on, Wednesday, June 5th, 2024
- Joel Beatty of "Baird" Maintained at Buy with Increased Target to $112 on, Tuesday, May 7th, 2024
- David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 7th, 2024
- Vikram Purohit of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $115 on, Monday, April 29th, 2024
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $107 on, Wednesday, April 10th, 2024
- Joon Lee of "Truist Securities" Maintained at Strong Buy and Held Target at $150 on, Tuesday, March 26th, 2024
Contributing Sources